U.S. Life Sciences Stock News

If you are wondering whether Cullen/Frost Bankers is good value at around US$140 per share, the key question is how that price compares with what the business might be worth. The stock has seen mixed recent moves, with a 1% decline over the last 7 days, a 1.9% gain over the last 30 days, and returns of 9.6% year to date and 10.6% over the last year, while the 3 year and 5 year returns sit at 21.2% and 44.4% respectively. Recent coverage of regional banks and interest rate expectations has...

Diversified Energy (NYSE:DEC) has agreed to acquire high working interest natural gas assets in East Texas, expanding its existing footprint in the region. The new properties sit near the company’s current operations, which may support operational synergies across production and infrastructure. Alongside the acquisition, Diversified Energy announced a fresh share buyback program and confirmed the completion of a prior repurchase tranche. Diversified Energy, trading at $14.52, is adding to...

Automatic Data Processing (NasdaqGS:ADP) has introduced a new AI agent ecosystem within ADP Marketplace. The launch focuses on automating HR workflows, including talent acquisition, compliance tasks, and operational insights. The AI agents are designed to integrate across ADP’s digital HR platform and support responsible AI use in workforce management. Automatic Data Processing, trading at $216.27, is adding this AI agent ecosystem at a time when many HR teams are looking to streamline...

Director Thomas T. Edman recently sold a significant block of TTM Technologies (NasdaqGS:TTMI) shares under a pre-established Rule 10b5-1 trading plan. The sale was disclosed in regulatory filings, giving investors fresh insight into insider transactions at the printed circuit board and electronics manufacturing company. For you as an investor, this kind of insider activity sits alongside fundamentals, valuation metrics, and your own risk tolerance. TTM Technologies focuses on advanced...

Chemours (NYSE:CC) and 2CRSi have entered into a joint development agreement focused on advanced cooling technologies for high-density IT and AI infrastructure. The partnership targets immersion and direct to chip cooling solutions tailored to data centers and AI driven environments. The agreement is positioned to support next generation chip applications and growing thermal management needs in digital infrastructure markets. Chemours, known for its specialty materials and chemistries, is...

AAON has reported that its Alpha Class EXTREME SERIES rooftop HVAC unit exceeded U.S. Department of Energy challenge standards. The unit delivered true simultaneous dual fuel operation while maintaining efficient performance at temperatures below typical industry requirements. The product is aimed at commercial buildings where retrofit friendly, high performance heating and cooling solutions are in demand. For investors watching NasdaqGS:AAON, this product news adds a fresh data point...

Marriott Vacations Worldwide (NYSE:VAC) recorded about $546 million in non-cash impairments tied to asset write downs and goodwill linked to earlier acquisitions. The company is reshaping its priorities toward profitability and free cash flow, including deferred or cancelled projects in Asia and fewer Asia Pacific tours planned for 2026. Leadership changes include Matt Avril stepping in as CEO and Mike Flaskey as President, signaling a new direction for the vacation ownership business. For...

Lineage, Inc. reported fourth-quarter 2025 sales of US$1,336 million, essentially flat year on year, but moved from a US$71 million net loss to a US$6 million net profit, with basic and diluted earnings per share from continuing operations improving from a loss of US$0.33 to earnings of US$0.03. For 2025 as a whole, Lineage’s sales edged up to US$5,355 million while its net loss narrowed sharply from US$664 million to US$100 million, indicating materially improved cost control and...

If you are wondering whether Sonic Automotive's current share price gives you genuine value, it helps to break the story into what the stock has done recently and what the fundamentals say about it. The shares most recently closed at US$62.62, with returns of 4.4% over 30 days, 1.6% year to date, a 3.2% decline over 1 year, 13.5% over 3 years and 38.0% over 5 years. Recent coverage around Sonic Automotive has focused on its position as a US auto retailer and how investors are weighing that...

Versant Media Group (NasdaqGS:VSNT) authorized a new $1b share repurchase program. The company declared a quarterly cash dividend, initiating regular capital returns to shareholders. Management highlighted recent acquisitions and progress in building Versant as a standalone public company. Versant Media Group, trading at $34.01 per share, is moving ahead with a mix of buybacks, dividends, and acquisitions that directly affect how capital is used. The stock is up 13.9% over the past week and...

If you are wondering whether Fortune Brands Innovations is fairly priced or offering hidden value at its current level, this article is designed to walk you through the key signals step by step. The stock recently closed at US$51.38, with returns of an 8.6% decline over 7 days, a 5.0% decline over 30 days, a 0.9% gain year to date, and a 14.4% decline over 1 year, plus longer term declines of 10.6% over 3 years and 26.0% over 5 years. Recent coverage has focused on how the share price...

Vir Biotechnology (VIR) is back in focus after its agreement with Astellas Pharma on prostate cancer candidate VIR-5500, along with fresh Phase 1 data and several recent equity financing moves. See our latest analysis for Vir Biotechnology. Despite a 4.6% 1-day share price decline to US$8.91 and some pressure over the past week, Vir Biotechnology’s roughly 20% 1-month and 42% 3-month share price returns suggest momentum has picked up around the Astellas partnership, Phase 1 VIR-5500 data and...

In recent weeks, Ameriprise Financial has faced insider share sales by several top executives, the planned retirement of a key Advice & Wealth Management leader, and an SEC fine related to compliance failures involving unapproved electronic messaging platforms. At the same time, its Columbia Threadneedle asset management arm was ranked by Barron's among the top fund families across 1-, 5-, and 10-year periods, underscoring the group’s long-term investment performance. We’ll examine how the...

Core Scientific (CORZ) just posted its FY 2025 Q4 numbers, reporting revenue of US$79.8 million, basic EPS of US$0.68 and net income of US$216.0 million. The company has seen quarterly revenue move in a tight band between US$78.6 million and US$95.4 million since late 2024, while basic EPS has swung from a loss of US$1.17 per share in 2024 Q3 to a profit of US$0.68 in 2025 Q4, highlighting how volatile margins have been for shareholders tracking the story. With trailing twelve month EPS still...

If you are wondering whether Church & Dwight is offering fair value at its current share price, you are not alone. This article is built to help you assess what you are really paying for. The stock last closed at US$103.02, with a 7.0% return over the past 30 days, a 24.7% return year to date, but a 5.7% decline over the past year and longer term returns of 27.6% over 3 years and 35.9% over 5 years. Recent interest in Church & Dwight reflects its position as a long established household...

Wondering whether Stoke Therapeutics at around US$33.78 is starting to look expensive or if there is still value on the table? This article walks through the key numbers so you can judge for yourself. The stock has been volatile, with a 4.8% decline over the last 7 days, an 11.3% gain over 30 days, a 9.3% return year to date, a 345.6% return over 1 year, a 266.0% return over 3 years, and a 34.9% decline over 5 years. These price swings sit against a backdrop of ongoing attention on Stoke...

CACI International (NYSE:CACI) has announced and priced a $500 million senior notes offering. The company plans to use the proceeds to help fund its acquisition of ARKA Group L.P. The transaction affects CACI International's capital structure and future debt obligations. For investors watching NYSE:CACI, this new senior notes offering comes at a time when the stock is trading at $629.75. The shares show longer term returns of 78.4% over the past year, 110.5% over three years, and 182.1%...

Conference appearance puts U.S. Gold in focus U.S. Gold (USAU) is set to present at the Emerging Growth Virtual Conference on February 25, 2026. Executive Chairman Luke Anthony Norman is expected to speak, drawing attention to potential commentary on projects and capital needs. See our latest analysis for U.S. Gold. At a share price of US$18.84, U.S. Gold has seen a 7 day share price return of 4.96% and a 30 day share price return of 8.65%. The 1 year total shareholder return of 125.90% and 3...

Axos Financial (AX) has been in focus after higher than expected inflation data raised doubts about near term rate cuts, putting pressure on bank stocks and sharpening investor attention on interest rate risk. See our latest analysis for Axos Financial. Despite the inflation driven sell off that recently hit Axos Financial, the current US$89.97 share price sits above its 90 day level, and the 1 year and 3 year total shareholder returns of 39.92% and 97.82% suggest momentum has been positive...

The Morning Bull - US Market Morning Update Wednesday, Mar, 4 2026 US stock futures are slightly softer this morning, with E-mini S&P 500 contracts down about 0.2%, as investors juggle stubborn inflation worries and mixed global growth signals. The US 10 year Treasury yield is holding near 4.06%, which indicates borrowing costs remain relatively high and keeps pressure on areas like real estate and smaller, debt heavy companies. At the same time, a large 5.6 million barrel build in US oil...

What Medline’s recent fundamentals mean for investors Medline (MDLN) has drawn fresh attention after investors focused on its latest reported fundamentals, including US$28.4b in revenue, US$1.2b in net income, and single digit annual growth rates across both measures. See our latest analysis for Medline. Despite US$28.4b of revenue and US$1.2b of net income drawing focus to fundamentals, Medline’s recent 1-day share price return of a 3.18% decline and 7-day share price return of an 11.2%...

AMETEK (AME) is in focus after reporting Q4 2025 earnings and revenue above forecasts, lifting its 2026 outlook, outlining a $100 million growth investment, and announcing a dividend increase that caught investors’ attention. See our latest analysis for AMETEK. Despite a 2.6% one day share price decline and a flat week, AMETEK’s 5.0% 30 day and 18.1% 90 day share price returns, alongside a 1 year total shareholder return of 29.2%, suggest momentum has recently been building. If this update...

GXO Logistics (NYSE:GXO) has entered a new partnership with lingerie retailer Hunkemoller to manage its B2B logistics. The agreement covers operations at a state of the art facility in Almere and is structured as a multi year deal. This is Hunkemoller’s first time outsourcing its B2B logistics operations to an external provider. For you as an investor, this move highlights how GXO Logistics (NYSE:GXO) positions itself as a specialist in complex, tech driven logistics for retailers. The...

NextDecade (NasdaqCM:NEXT) approved positive final investment decisions on Trains 4 and 5 at its Rio Grande LNG Facility. The company executed multiple long term LNG sale and purchase agreements tied to these additional trains. These steps expand NextDecade's planned LNG production capacity and build out its contracted commercial portfolio. NextDecade focuses on developing LNG export capacity at its Rio Grande LNG Facility, positioning itself as a US Gulf Coast supplier to global buyers...